Literature DB >> 23677384

Decreased expression of miR-430 promotes the development of bladder cancer via the upregulation of CXCR7.

Lei Liu1, Xiaokun Zhao, Xuan Zhu, Zhaohui Zhong, Ran Xu, Zijian Wang, Jian Cao, Yi Hou.   

Abstract

MicroRNAs (miRNAs) have been demonstrated to be involved in the development of numerous types of malignant tumor. However, the role of miRNA-430 (miR-430) in bladder cancer remains unclear. In the present study, we observed that the expression of miR-430 was significantly downregulated in bladder cancer. Furthermore, the overexpression of miR-430 in human bladder cancer 5637 cells significantly inhibited cell proliferation, migration and colony formation efficiency. These findings were contrary to those obtained following the overexpression of CXCR7, which was found to be a direct target of miR-430 in this study. Further analysis showed that cell proliferation- and migration-related genes, including ERK, matrix metalloproteinase-2 (MMP-2) and MMP-9, were significantly downregulated in miR-430 overexpressed 5637 cells, while they were markedly upregulated in CXCR7 overexpressed 5637 cells. In conclusion, our study reveals important roles of miR-430 and CXCR7 in bladder cancer, and suggests that the downregulation of miR-430 enhances the development of bladder cancer, partly via the upregulation of CXCR7.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677384     DOI: 10.3892/mmr.2013.1477

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  16 in total

Review 1.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

2.  ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells.

Authors:  Weiran Gao; Xifan Mei; Jikun Wang; Xianglin Zhang; Yajiang Yuan
Journal:  Tumour Biol       Date:  2015-04-20

Review 3.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

4.  Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP-9 signaling pathways in human bladder cancer cells.

Authors:  Tian Li; Kewei Xu; Yifan Liu
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

5.  LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer.

Authors:  Ri Chen; Chunfan Zhang; Yuanda Cheng; Shaoqiang Wang; Hang Lin; Heng Zhang
Journal:  Lab Invest       Date:  2021-04-06       Impact factor: 5.662

Review 6.  Chemokines and microRNAs in atherosclerosis.

Authors:  Petra Hartmann; Andreas Schober; Christian Weber
Journal:  Cell Mol Life Sci       Date:  2015-05-23       Impact factor: 9.261

7.  MicroRNAs in the Regulation of MMPs and Metastasis.

Authors:  Mohammed Abba; Nitin Patil; Heike Allgayer
Journal:  Cancers (Basel)       Date:  2014-03-25       Impact factor: 6.639

8.  MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.

Authors:  Wentao Liu; Lin Qi; Hui Lv; Xiongbing Zu; Minfeng Chen; Jun Wang; Longfei Liu; Feng Zeng; Yuan Li
Journal:  BMC Cancer       Date:  2015-03-04       Impact factor: 4.430

Review 9.  Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.

Authors:  Cecilia Pop-Bica; Diana Gulei; Roxana Cojocneanu-Petric; Cornelia Braicu; Bogdan Petrut; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

10.  CXCR7 functions in colon cancer cell survival and migration.

Authors:  Hongxian Wang; Linyu Tao; K E Qi; Haoyun Zhang; Duo Feng; Wenjun Wei; Heng Kong; Tianwen Chen; Qiusheng Lin; Daojin Chen
Journal:  Exp Ther Med       Date:  2015-09-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.